Bioactive glass S53P4 in the filling of cavities in the mastoid cell area in surgery for chronic otitis media

Annals of Otology, Rhinology and Laryngology

Volumn 119, Issue 6, 2010, Pages 377-382

  Stoor, Patricia ^a   Pulkkinen, Jaakko ^b   Grénman, Reidar ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Bioactive glass; Otitis media; Surgical treatment

Indexed keywords

BIOMATERIAL; GLASS;

ADULT; AGED; ARTICLE; CHOLESTEATOMA; CHRONIC OTITIS MEDIA; CLEANING; CLINICAL ARTICLE; FEMALE; HUMAN; LONG TERM CARE; MALE; MASTOID; MASTOIDECTOMY; MUCOSA; PRIORITY JOURNAL;

EID: 77953493187     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348941011900603     Document Type: Article

References (35)

1. Chole RA, Sudhoff HH. Chronic otitis media, mastoiditis and petrositis. In: Cummings CW, Haughey BH, Thomas JR, et al, eds. Cummings otolaryngology-head and neck surgery. 4th ed. St Louis, Mo: Elsevier Mosby, 2005:2988-3012.
2. Palva T. Mastoid obliteration. Acta Otolaryngol Suppl 1979;360:152-4.
3. Lee WS, Choi JY, Song MH, Son EJ, Jung SH, Kim SH. Mastoid and epitympanic obliteration in canal wall up mastoidectomy for prevention of retraction pocket. Otol Neurotol 2005; 26:1107-11.
4. Roberson JB Jr, Mason TP, Stidham KR. Mastoid obliteration: autogenous cranial bone pâte reconstruction. Otol Neurotol 2003;24:132-40.
5. Peltola M. Use of Bioactive Glass S53P4 in frontal sinus obliteration and in reconstruction of facial bone defects. Vivoxid report: Summary of clinical trials. 30.4.2004, 16-20.
6. Leatherman BD, Dornhoffer JL. Bioactive glass ceramic particles as an alternative for mastoid obliteration: results in an animal model. Otol Neurotol 2002;23:657-60.
7. Stoor P, Söderling E, Grenman R. Interactions between the bioactive glass S53P4 and the atrophic rhinitis-associated microorganism Klebsiella ozaenae. J Biomed Mater Res 1999; 48:869-74.
8. Stoor P, Söderling E, Grénman R. Bioactive glass S53P4 in repair of septal perforations and its interactions with the respiratory infection-associated microorganisms Haemophilus influenzae and Streptococcus pneumoniae. J Biomed Mater Res 2001;58:113-20.
9. Stoor P, Kirstilä V, Söderling E, Kangasniemi I, yli-Urpo A. Interactions between bioactive glass and periodontal pathogens. Microb Ecol Health Disease 1996;9:109-14.
10. Wilson J, Pigott GH, Schoen FJ, Hench LL. Toxicology and biocompatibility of bioglasses. J Biomed Mater Res 1981; 15:805-17.
11. Suominen E, Kinnunen J. Bioactive glass granules and palates in the reconstruction of defects of the facial bones. Scand J Plast Reconstr Surg Hand Surg 1996;30:281-9. (Pubitemid 26418030)
12. Aitasalo K, Peltola MJ. Bioactive glass hydroxyapatite in fronto-orbital defect reconstruction. Plast Reconstr Surg 2007; 120:1963-74.
13. Suonpää J, Sipilä J, Aitasalo K, Antila J, Wide K. Operative treatment of frontal sinusitis. Acta Otolaryngol Suppl 1997; 529:181-3.
14. Peltola M, Suonpää J, Aitasalo K, Varpula M, yli-Urpo A, Happonen R-P. Obliteration of the frontal sinus cavity with bioactive glass. Head Neck 1998;20:315-9.
15. Stoor P, Grénman R. Bioactive glass and turbinate flaps in the repair of nasal septal perforations. Ann Otol Rhinol Laryngol 2004;113:655-61. (Pubitemid 39031111)
16. Hench LL, Paschall HA. Direct chemical bond of bioactive glass-ceramic materials to bone and muscle. J Biomed Mater Res 1973;7:25-42.
17. Hench LL, Splinter RJ, Allen WC, Greenlee TK. Bonding mechanism at the interface of ceramic prosthetic materials. J Biomed Mater Res 1971;5:117-41.
18. Häkkinen L, yli-Urpo A, Heino J, Larjava H. Attachment and spreading of human gingival fibroblasts on potentially bioactive glasses in vitro. J Biomed Mater Res 1988;22:1043-59.
19. Heikkilä JT, Aho AJ, yli-Urpo A, Andersson OH, Aho HJ, Happonen R-P. Bioactive glass versus hydroxylapatite in reconstruction of osteochondral defects in the rabbit. Acta Orthop Scand 1993;64:678-82.
20. Schepers E, de Clercq M, Ducheyne P, Kempeneers R. Bioactive glass particulate material as a filler for bone lesions. J Oral Rehab 1991;18:439-52.
21. Stoor P, Söderling E, Salonen JI. Antibacterial effects of a bioactive glass paste on oral microorganisms. Acta Odontol Scand 1998;56:161-5.
22. Tirri T, Söderling E, Malin M, Peltola M, Seppälä JV, Närhi TO. Adhesion of respiratory-infection-associated microorganisms on degradable thermoplastic composites. International Journal of Biomaterials 2009; article ID 765813, 6 pages.
23. Minatowaga T, Machizuka H, Kumoi T. Evaluation of mas toid obliteration surgery. Am J Otol 1995;16:99-103.
24. Zohar y, Talmi yP, Strauss M, Finkelstein y, Shvilli y. Ozena revisited. J Otolaryngol 1990;19:345-9.
25. Linthicum FH Jr. The fate of mastoid obliteration tissue: a histopathological study. Laryngoscope 2002;112:1777-81.
26. Ramsey MJ, Merchant SN, McKenna MJ. Postauricular periosteal-pericranial flap for mastoid obliteration and canal wall down tympanomastoidectomy. Otol Neurotol 2004;25:873-8.
27. Dornhoffer JL. Surgical modification of the difficult mastoid cavity. Otolaryngol Head Neck Surg 1999;120:361-7.
28. Grote JJ, van Blitterswijk CA. Reconstruction of the posterior auditory canal wall with a hydroxyapatite prosthesis. Ann Otol Rhinol Laryngol Suppl 1986;95(suppl 123):6-9.
29. Lenis A. Treatment of the intractable chronically draining mastoid cavity with hydroxylapatite covered with temporalis flap. Laryngoscope 1988;98:1271-2.
30. Jahn AF. Experimental applications of porous (coralline) hydroxylapatite in middle ear and mastoid reconstruction. Laryngoscope 1992;102:289-99.
31. Mahendran S, yung MW. Mastoid obliteration with hydroxyapatite cement: the Ipswich experience. Otol Neurotol 2004;25:19-21.
32. Clark MPA, Bottrill I. SerenoCem-glass ionomeric granules: a 3-year follow-up assessment of their effectiveness in mastoid obliteration. Clin Otolaryngol 2007;32:287-90.
33. Wadström T. Molecular aspects of bacterial adhesion, col onization, and development of infections associated with bio materials. J Invest Surg 1989;2:353-60. (Pubitemid 20143844)
34. Aho AJ, Hirn M, Aro HT, Heikkilä JT, Meurman O. Bone bank service in Finland. Experience of bacteriologic, serologic and clinical results of the Turku Bone Bank 1972-1995. Acta Orthop Scand 1998;69:559-65.
35. Sailer HF, Grätz KW, Kalavrezos ND. Frontal sinus fractures: principles of treatment and long-term results after sinus obliteration with the use of lyophilized cartilage. J Craniomaxillofac Surg 1998;26:235-42.